Published: 27 Sep 2024(Updated: 27 Sep 2024)
•33 min
•33 min read
•Jihen Melki, Thierry-Borel N'dri Kouadio, Mireille Nowakowski, Zara Razafiarimanga, Man-Koumba Soumahoro, Stephane Peltres, Ronan JambouProduction and evaluation of a new set of recombinant antigens for the serological diagnosis of human cysticercosis
Researchers from the Department of Parasitology-Mycology at Institut Pasteur de Côte d'Ivoire are exploring new solutions for diagnosing human cysticercosis in remote areas. Their study tested a set of recombinant antigens for use in ELISA assays as a low-cost alternative to neuroimaging. While some challenges remain in optimizing sensitivity, the results show great promise, particularly in regions with limited medical resources. These antigens could provide a crucial screening tool for detecting neurocysticercosis, especially in patients with epilepsy, helping those in remote areas access better diagnosis and care.